TWI Trademark

Trademark Overview


On Monday, November 28, 2011, a trademark application was filed for TWI with the United States Patent and Trademark Office. The USPTO has given the TWI trademark a serial number of 85481793. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, December 12, 2023. This trademark is owned by TWi Pharmaceuticals, Inc.. The TWI trademark is filed in the Advertising, Business and Retail Services, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacturing in the field of new and generic pharmaceutical products, including delivery systems such as controlled release formulations, and systems that include the use of nanoparticles, transdermal, microencapsulation, and polymeric oral delivery systems

Commercialization, namely, commercial feasibility studies in the field of new and generic pharmaceutical products, including delivery systems such as controlled release formulations, and systems that include the use of nanoparticles, transdermal, microencapsulation, and polymeric oral delivery systems

Research, and development of new and generic pharmaceutical products, including delivery systems such as controlled release formulations, and systems that include the use of nanoparticles, transdermal, microencapsulation, and polymeric oral delivery systems
twi

General Information


Serial Number85481793
Word MarkTWI
Filing DateMonday, November 28, 2011
Status800 - REGISTERED AND RENEWED
Status DateTuesday, December 12, 2023
Registration Number4377197
Registration DateTuesday, July 30, 2013
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 11, 2012

Trademark Statements


Goods and ServicesCustom manufacturing in the field of new and generic pharmaceutical products, including delivery systems such as controlled release formulations, and systems that include the use of nanoparticles, transdermal, microencapsulation, and polymeric oral delivery systems
Description of MarkThe mark consists of italicized capital letters "T" and "W" followed by italicized lower case letter "i", with the dot above the "i" represented by a sunburst.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesCommercialization, namely, commercial feasibility studies in the field of new and generic pharmaceutical products, including delivery systems such as controlled release formulations, and systems that include the use of nanoparticles, transdermal, microencapsulation, and polymeric oral delivery systems
Goods and ServicesResearch, and development of new and generic pharmaceutical products, including delivery systems such as controlled release formulations, and systems that include the use of nanoparticles, transdermal, microencapsulation, and polymeric oral delivery systems

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, July 3, 2012
Primary Code035
First Use Anywhere DateThursday, January 27, 2011
First Use In Commerce DateThursday, January 27, 2011

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, July 3, 2012
Primary Code040
First Use Anywhere DateThursday, January 27, 2011
First Use In Commerce DateThursday, January 27, 2011

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 3, 2012
Primary Code042
First Use Anywhere DateThursday, January 27, 2011
First Use In Commerce DateThursday, January 27, 2011

Trademark Owner History


Party NameTWi Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTaipei 114
TW

Party NameTWi Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTaipei 114
TW

Party NameTWi Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTaipei 114
TW

Trademark Events


Event DateEvent Description
Tuesday, December 12, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, December 12, 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, December 12, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, December 8, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, June 13, 2023TEAS SECTION 8 & 9 RECEIVED
Saturday, July 30, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sunday, September 8, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, September 8, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sunday, September 8, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, July 30, 2019TEAS SECTION 8 & 15 RECEIVED
Monday, July 30, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 30, 2013REGISTERED-PRINCIPAL REGISTER
Thursday, June 27, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, June 26, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, June 26, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 5, 2013STATEMENT OF USE PROCESSING COMPLETE
Monday, May 6, 2013USE AMENDMENT FILED
Friday, May 24, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 6, 2013TEAS STATEMENT OF USE RECEIVED
Tuesday, November 6, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 11, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 11, 2012PUBLISHED FOR OPPOSITION
Wednesday, August 22, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 7, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 7, 2012ASSIGNED TO LIE
Tuesday, July 24, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 3, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 3, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 3, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 10, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 10, 2012NON-FINAL ACTION E-MAILED
Saturday, March 10, 2012NON-FINAL ACTION WRITTEN
Saturday, March 10, 2012ASSIGNED TO EXAMINER
Saturday, December 3, 2011NOTICE OF DESIGN SEARCH CODE MAILED
Friday, December 2, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 1, 2011NEW APPLICATION ENTERED